Should a history of assisted reproductive technology be another consideration when assessing cardiovascular risk?
Should a history of assisted reproductive technology be another consideration when assessing cardiovascular risk?
复制标题
在评估心血管风险时，辅助生殖技术的历史是否应该成为另一个考虑因素？
DOI：
10.1111/jch.12937
复制
发表时间：
2017
期刊：
影响因子：
--
通讯作者：
Callegari,LisaS
中科院分区：
文献类型：
--
作者：
Goldstein,KarenM;Callegari,LisaS
Women make up 51% of the population and face cardiovascular disease (CVD) as the leading cause of death just as men do; however, clinical presentations and risk factors for heart disease common to women have long been labeled as “atypical.” The recent conversation in CVD is shifting to define disease in women independently from men, recognizing that gender-and sex-based differences in pathophysiology, and not just disparities, need to be considered. 1 In 2011, Mosca and colleagues2 put forth an evidence-based set of guidelines for the prevention of CVD specific to women. This year, the American Heart Association released a statement outlining current scientific knowledge about predisposing factors for the development of ischemic heart disease in women. 3 Each of these publications identifies important female-specific risk factors for CVD, including complications of pregnancy such as preeclampsia and other pregnancy-related hypertensive disorders. This formal recognition of the import of gestational events in long-term CVD risk demands that clinicians reconsider pregnancy as the first “stress test” for women4 and places emphasis on obtaining a thorough pregnancy history in cardiovascular risk assessments. 2 The article by Thomopoulos and colleagues highlights an additional aspect of pregnancy history that warrants consideration in CVD risk discussions for women: the use of assisted reproductive technology (ART).
